Effect of atropine eye drop for inhibition of myopic progression

Study of the effect of atropine eye drops with concentration of 0.1%&0.01% and placebo in natural course of myopia progression in Children with 6 to 18 year olds

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20100414003714N3

Enrollment

Registered

2018-07-10

Start date

2018-06-20

Completion date

Unknown

Last updated

2018-09-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Inhibition of myopic progression with using atropine eye drop. Myopia

Interventions

Intervention 1: Intervention group 1: Receive 0.1% atropine eye drops. Intervention 2: Intervention group2: Receive 0.01% atropine eye drops. Intervention 3: Control group: receive artificial tear e

Eligibility

Sex/Gender

All

Age

6 Years to 18 Years

Inclusion criteria

Inclusion criteria: aged 6-18 Myopia astigmatism (2-6 diopter) No amblyopia

Exclusion criteria

Exclusion criteria: Age under 6 and over 18 Amblyopia Strabismus

Design outcomes

Primary

Measure	Time frame
Percent of myopic power and axial length changes. Timepoint: 6 months after discontinuation of atropine 0.1% and 0.01% eye drop and placebo. Method of measurement: Auto refractometer and ultrasound.	—

Secondary

Measure	Time frame
Myopic power and axial length changes 6 months after treatment withdrawal. Timepoint: 6 months after discontinuation of atropine 0.1% and 0.01% eye drop and. Method of measurement: Auto refractometer and ultrasound.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAbdolreza medghalchi

Guilan University of Medical Aciences

rezamed1340@yahoo.com+98 13 3323 6886

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026